PGx101 Certificate Program

Earn a Certificate in Pharmacogenomics

Facilitating the training are Dan Krinsky, BS, MS, RPh and Sue Paul, RPh, PGx101 Co-Founders.
This program enables attendees to learn by using real genetic data in highly interactive exercises.

Earn 16 ACPE accredited continuing education credit hours

Activity Description
Key features: This certificate training program delivers the most comprehensive curriculum with an experienced faculty involved in the development and delivery of the content. We offer flexibility in scheduling and establish deadlines for completion of the self-study portion to hold participants accountable for completion which will lead to better opportunities for implementation. This program also offers comprehensive assessments and myriad case studies, along with an opportunity for follow-up after the program. Group pricing is also available, please reach out to us for more information.

The 16-hour ACPE-accredited certificate program enables students to learn by using real genetic data in highly-interactive exercises with an optional activity for learners to undergo personal genomic testing. The Certificate Program is comprised of:

• 12 hours of home study
• 8 hours of live training

Program breakdown:

Self-Study Modules: Will have to be completed before the live programming (12 hours of CE)

1. Foundations of Pharmacogenomics 
2. Pharmacogenomic drug exposure and response
3. Pharmacogenomic testing
4. Pharmacists Patient Care Process
5. Cardiology: clopidogrel
6. Neurology: clopidogrel
7. Cardiology: simvastatin
8. Immunology: tacrolimus
9. Neurology: carbamazepine
10. Neurology: phenytoin
11. Psychiatry: amitriptyline
12. Psychiatry: paroxetine
13. Psychiatry: atomoxetine
14. Rheumatology/Musculoskeletal: codeine

Live programming: (4 hours of CE)

1. Pharmacist competencies
2. Implementation across practice settings
3. Information resources
4. Ethical/social/regulatory contexts
5. PGx and secondary findings
6. Legislative
7. Insurance/payment
8. Review of recent evidence in the primary literature

---

The target audience for the certificate program is pharmacists in all practice settings including community, ambulatory care, inpatient, professional associations, and academia. While the program is primarily designed for pharmacists, student pharmacists and non-pharmacists interested in pharmacogenomics are also welcome to complete the program.

Completion of all components of the certificate training program, home study and live sessions, is necessary to obtain the full 16 contact hours of continuing pharmacy education. Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.

Learning Objectives:

Upon completion of the PGx101 Pharmacogenomics Certificate Training Program home study modules and live programming, the participant will be able to:

1. Understand principles and foundational knowledge of pharmacogenomics, including its role in precision medicine.
2. Identify genetic variants that influence drug metabolism, efficacy, and toxicity.
3. Explore drug-gene interactions that impact drug absorption, distribution, metabolism, and excretion (ADME).
4. Develop skills in interpreting laboratory reports and genetic test results to guide clinical decision-making.
5. Demonstrate how to incorporate pharmacogenomic insights into patient care to optimize therapeutic outcomes.
6. Understand regulatory and ethical considerations and address the ethical, legal, social, and regulatory implications of pharmacogenomic testing and personalized medicine.
7. Utilize patient-centered communication focused on pharmacogenomic information effectively to patients and other healthcare professionals.
8. Evaluate evidence-based resources that are used to access, evaluate, and apply pharmacogenomic literature and guidelines in clinical practice.
9. Apply pharmacogenomics in special populations taking into consideration age, ethnicity, and comorbidities.
10. Use real-world scenarios to practice applying pharmacogenomic knowledge to patient care, with a focus on specific medications for cardiology, immunology, neurology, psychiatry, and rheumatology/musculoskeletal conditions.
11. Understand laboratory techniques and laboratory methods used in pharmacogenomics, such as genotyping and sequencing.
12. Develop collaborative skills and promote interdisciplinary collaboration between pharmacists, geneticists, and other healthcare providers.
13. Implement clinical decision support tools using electronic health records that incorporate pharmacogenomic data.
14. Assess cost-effectiveness of pharmacogenomics and explore the economic implications of pharmacogenomics, including cost-benefit analyses for healthcare systems.
15. Be prepared to discuss ways to engage in clinical research or quality improvement projects to further the field of pharmacogenomics.